AIN HoldingsAIN HOLDINGS INC.9627東証プライム小売業FY ending Apr 2026, consolidated, J-GAAP
About 93% of AIN Holdings's sales come from Dispensing pharmacy, with Drug and cosmetic store making up much of the rest.
Out of every ¥100 of sales, about ¥5 is left as operating profit.
Revenue changed +6.4% from the prior year, operating profit +38.5%.
Revenue +6.4% · profit +38.5%, calculated from disclosed figures.
Operating leverage: 6.04× (profit growth ÷ revenue growth)
FY ending Apr 2021 → FY ending Apr 2022
FY ending Apr 2021 → FY ending Apr 2022
※ Segment revenues include inter-segment sales and are scaled to consolidated revenue
For every ¥100 AIN Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書－第57期(2025/05/01－2026/04/30)
EDINET (FSA Japan)
有価証券報告書－第56期(2024/05/01－2025/04/30)
EDINET (FSA Japan)
有価証券報告書－第55期(2023/05/01－2024/04/30)
EDINET (FSA Japan)
訂正有価証券報告書－第54期(2022/05/01－2023/04/30)
EDINET (FSA Japan)
有価証券報告書－第53期(令和3年5月1日－令和4年4月30日)
EDINET (FSA Japan)
有価証券報告書－第52期(令和2年5月1日－令和3年4月30日)
Extracted from XBRL: 53 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.